The regulatory agenda is set to continue shaping the structured products market in Europe and beyond. In the first of two articles about the 2017 regulatory agenda, Ashurst's global derivatives and structured products team talks about the issues surrounding Packaged Retail and Insurance-based Investment Products (Priips) and the Markets in Financial Instruments Directive (Mifid 2), and the need to define the responsibilities of the manufacturer and the distributor. Priips Key Information Docume

Continue reading and get unlimited access for 7 days with a free trial of SRP.

Get a free trial

Already a subscriber? Login